GARS1 and peripheral neuropathy: Finally, even high-level expression of the only reported PN-GlyRS variant that removes a positive charge from the GlyRS protein (K456Q) does not induce peripheral neuropathy phenotypes, and hGlyRS-K456Q displays WT-like aminoacylation activity, suggesting that K456Q may not be a pathogenic mutation.